Cellebrite DI Ltd. announced on August 14, 2024, that it triggered a price condition leading to the issuance of 5,000,000 ordinary shares to shareholders and the vesting of 3,000,000 shares after meeting specific criteria from a merger agreement. This is a significant event regarding company stock adjustments.